We are live on ! Find out more
JIC

Johnson Investment Counsel Portfolio holdings

AUM $13.7B
1-Year Est. Return 21.52%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+21.52%
3 Year Est. Return
+66.26%
5 Year Est. Return
+83.65%
10 Year Est. Return
+316.44%
AUM
$7.78B
AUM Growth
-$283M
Cap. Flow
+$47M
Cap. Flow %
0.61%
Top 10 Hldgs %
31.45%
Holding
720
New
51
Increased
279
Reduced
238
Closed
43

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$31.2M
2
NOC icon
Northrop Grumman
NOC
+$19.9M
3
EL icon
Estee Lauder
EL
+$18.6M
4
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$10.3M
5
GPC icon
Genuine Parts
GPC
+$8.14M

Top Sells

Rank Stock Value
1
NVT icon
nVent Electric
NVT
+$35.7M
2
ABBV icon
AbbVie
ABBV
+$19.9M
3
TJX icon
TJX Companies
TJX
+$11.5M
4
HUBB icon
Hubbell
HUBB
+$9.77M
5
AAPL icon
Apple
AAPL
+$9.71M

Sector Composition

Rank Sector Weight
1 Technology 16.37%
2 Financials 13.7%
3 Healthcare 10.58%
4 Consumer Staples 9.17%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAN icon
651
Banco Santander
SAN
$210B
$145K ﹤0.01%
38,440
SID icon
652
Companhia Siderúrgica Nacional
SID
$1.14B
$136K ﹤0.01%
57,100
ITUB icon
653
Itaú Unibanco
ITUB
$83.1B
$133K ﹤0.01%
28,098
GGB icon
654
Gerdau
GGB
$9.27B
$130K ﹤0.01%
32,760
RPAY icon
655
Repay Holdings
RPAY
$315M
$126K ﹤0.01%
16,600
NRK icon
656
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$922M
$124K ﹤0.01%
13,110
TV icon
657
Televisa
TV
$1.49B
$119K ﹤0.01%
+39,000
New +$171K
PSTX
658
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$111K ﹤0.01%
46,758
TG icon
659
Tredegar Corp
TG
$280M
$81.2K ﹤0.01%
+15,000
New +$87.5K
RSKD icon
660
Riskified
RSKD
$712M
$76K ﹤0.01%
+16,965
New +$78.1K
ABEV icon
661
Ambev
ABEV
$44B
$72.2K ﹤0.01%
28,000
GAB icon
662
Gabelli Equity Trust
GAB
$1.79B
$70.8K ﹤0.01%
13,804
+294
+2% +$1.61K
RPT
663
Rithm Property Trust
RPT
$98.2M
$67.3K ﹤0.01%
1,742
TMC icon
664
TMC The Metals Company
TMC
$1.95B
$64.2K ﹤0.01%
64,730
CCLD icon
665
CareCloud
CCLD
$106M
$57.5K ﹤0.01%
50,000
CLNE icon
666
Clean Energy Fuels
CLNE
$381M
$56.4K ﹤0.01%
14,725
LWLG icon
667
Lightwave Logic
LWLG
$1.16B
$51.2K ﹤0.01%
11,465
TDUP icon
668
ThredUp
TDUP
$407M
$41.1K ﹤0.01%
+10,242
New +$34.7K
BLUE
669
DELISTED
bluebird bio
BLUE
$40.2K ﹤0.01%
+660
New +$46.4K
MXCT icon
670
MaxCyte
MXCT
$134M
$33.7K ﹤0.01%
+10,815
New +$43.5K
LYG icon
671
Lloyds Banking Group
LYG
$88.8B
$26.9K ﹤0.01%
+12,632
New +$27.4K
PRCH icon
672
Porch Group
PRCH
$1.79B
$22K ﹤0.01%
+27,431
New +$28.8K
EGIO
673
DELISTED
Edgio, Inc. Common Stock
EGIO
$8.69K ﹤0.01%
255
-250
-50% -$7.83K
WKHS icon
674
Workhorse Group
WKHS
$33.8M
$8.25K ﹤0.01%
7
+1
+17% +$2.57K
BODI icon
675
The Beachbody Company
BODI
$45.3M
$5.4K ﹤0.01%
366

Similar funds

Johnson Investment Counsel's Q3 2023 Portfolio in Review

As of Q3 2023, Johnson Investment Counsel held 720 positions worth $7.78B, down 3.5% from $8.06B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Johnson Investment Counsel's Q3 2023 filing shows 51 new, 279 increased, 238 reduced and 43 closed positions. Its largest new stake was Dynatrace: 57,284 shares worth $2.68M. The largest sale was nVent Electric, an estimated $35.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Johnson Investment Counsel's largest Q3 2023 buy was Dynatrace: 57,284 shares worth $2.68M.
  • Johnson Investment Counsel added most to ASML in Q3 2023, an estimated $31.2M increase.
  • Johnson Investment Counsel's biggest Q3 2023 reduction was nVent Electric, cutting an estimated $35.7M.
  • Johnson Investment Counsel fully exited AbbVie in Q3 2023, selling an estimated $19.9M.
  • Johnson Investment Counsel's ten largest holdings make up 31% of its $7.78B portfolio in Q3 2023.
  • Johnson Investment Counsel opened 51 new positions and closed 43 in Q3 2023.
  • Johnson Investment Counsel's portfolio value fell 3.5% quarter-over-quarter to $7.78B.

Based on Johnson Investment Counsel's 13F filing for Q3 2023, filed 13 Nov 2023.